Article Type
Audio
Changed
Thu, 12/15/2022 - 15:08
Display Headline
Psoriasis Treatment With Tumor Necrosis Factor Inhibitors
Author(s)
Jashin J. Wu, MD

Author and Disclosure Information

From the Department of Dermatology, Kaiser Permanente Los Angeles Medical Center.

Publications
Cutis
MDedge Dermatology
Psoriasis Collection
B-Cell Lymphoma ICYMI
Breast Cancer ICYMI
Topics
Psoriasis
Sections
Clinical Topics & News
Author(s)
Jashin J. Wu, MD
Author(s)
Jashin J. Wu, MD
Author and Disclosure Information

From the Department of Dermatology, Kaiser Permanente Los Angeles Medical Center.

Author and Disclosure Information

From the Department of Dermatology, Kaiser Permanente Los Angeles Medical Center.

Related Articles
Combination Therapy With Tumor Necrosis Factor Inhibitors in Psoriasis Treatment
Etanercept Improves Psoriatic Arthritis Patient-Reported Outcomes: Results From EDUCATE
Sequential Use of Infliximab and Etanercept in Generalized Pustular Psoriasis
Successful Treatment of Recalcitrant Palmoplantar Psoriasis With Etanercept
Biologic Therapy for Psoriasis: A Brief History, I
Biologic Therapy for Psoriasis: A Brief History, II

Publications
Cutis
MDedge Dermatology
Psoriasis Collection
B-Cell Lymphoma ICYMI
Breast Cancer ICYMI
Publications
Cutis
MDedge Dermatology
Psoriasis Collection
B-Cell Lymphoma ICYMI
Breast Cancer ICYMI
Topics
Psoriasis
Article Type
Audio
Display Headline
Psoriasis Treatment With Tumor Necrosis Factor Inhibitors
Display Headline
Psoriasis Treatment With Tumor Necrosis Factor Inhibitors
Sections
Clinical Topics & News
Disallow All Ads
Alternative CME
Use ProPublica
Teaser Media